- Report
- May 2024
- 130 Pages
Global
From €5704EUR$6,499USD£4,935GBP
- Drug Pipelines
- February 2024
- 144 Pages
Global
From €6977EUR$7,950USD£6,037GBP
- Report
- April 2023
- 117 Pages
Global
From €4169EUR$4,750USD£3,607GBP
- Report
- October 2023
- 300 Pages
Global
From €2194EUR$2,500USD£1,898GBP
Reglan (metoclopramide) is a gastrointestinal drug used to treat symptoms of gastroesophageal reflux disease (GERD) and gastroparesis. It is a dopamine antagonist that works by blocking the action of dopamine in the brain, which helps to reduce nausea and vomiting. It is also used to treat symptoms of irritable bowel syndrome (IBS) and to prevent nausea and vomiting caused by chemotherapy. Reglan is available in both oral and injectable forms.
Reglan is a widely used drug in the gastrointestinal market, with a variety of applications. It is used to treat a range of gastrointestinal conditions, including GERD, gastroparesis, and IBS. It is also used to prevent nausea and vomiting caused by chemotherapy. Reglan is available in both oral and injectable forms, making it a versatile treatment option.
Companies in the Reglan market include Pfizer, Novartis, Merck, and Sanofi. Show Less Read more